<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Dr Laura Jacobs on Medium]]></title>
        <description><![CDATA[Stories by Dr Laura Jacobs on Medium]]></description>
        <link>https://medium.com/@ljacobs_79852?source=rss-fd0c652f8686------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*hp77CcNOlAlZNym1BJvPWw.jpeg</url>
            <title>Stories by Dr Laura Jacobs on Medium</title>
            <link>https://medium.com/@ljacobs_79852?source=rss-fd0c652f8686------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Mon, 16 Nov 2026 04:17:04 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@ljacobs_79852/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[PPI at Parkinson’s UK: reflecting on 2025 and looking ahead in 2026]]></title>
            <link>https://medium.com/researchinvolvement/ppi-at-parkinsons-uk-reflecting-on-2025-and-looking-ahead-in-2026-65ff1a10c1aa?source=rss-fd0c652f8686------2</link>
            <guid isPermaLink="false">https://medium.com/p/65ff1a10c1aa</guid>
            <category><![CDATA[patient-engagement]]></category>
            <category><![CDATA[research]]></category>
            <category><![CDATA[parkinsons]]></category>
            <category><![CDATA[lived-experience]]></category>
            <dc:creator><![CDATA[Dr Laura Jacobs]]></dc:creator>
            <pubDate>Fri, 30 Jan 2026 11:04:21 GMT</pubDate>
            <atom:updated>2026-01-30T11:07:35.761Z</atom:updated>
            <content:encoded><![CDATA[<p><strong>2025 was a busy year for the Patient and Public Involvement (PPI) programme with many activities to support and improve PPI at Parkinson’s UK. In this blog, we reflect back on our highlights and activities from the year and look to the year ahead.</strong></p><h3>Key statistics and highlights</h3><p>In 2025 we supported researchers and people affected by Parkinson’s to work together in <strong>over 80 research projects.</strong> This is the highest number of projects in a year yet. And it doesn’t include the many long term collaborations, like advisory groups or steering committees, that many of you are involved with which started before 2025.</p><p>One exciting example is the EJSACT-PD study, the world’s largest Parkinson’s clinical trial which uses an innovative design and launched in 2025. It has been shaped throughout by people affected by Parkinson’s, including many of you. As Carroll, who is a member of the involvement group explains,</p><blockquote>‘[We] share our thoughts on how the trial should be managed, what treatment to choose, what technology should be used for monitoring, where the sites should be etc.’</blockquote><p><a href="https://www.parkinsons.org.uk/research/blog/trials-treatments/collaborating-make-ejs-act-pd-happen">Read more about the collaboration behind the EJSACT-PD study in our blog</a>.</p><p>In 2025 we welcomed 26 new PPI contributors to the role, bringing the network up to 138 volunteers! It’s been a pleasure to meet and connect with many of you in our new ‘PPI Quarterly Connections’ online calls this year.</p><p>Whether you’re new to the role or have been a volunteer for many years, thank you for all you do to improve Parkinson’s research. Together you’re helping to make Parkinson’s research more relevant, inclusive, practical and engaging.</p><h3>Beyond the numbers</h3><p>We’re thrilled to see more and more Parkinson’s research, from lab based projects to clinical trials, being shaped by people living with Parkinson’s and those who support them. But we know there’s more to do.</p><p><a href="https://medium.com/researchinvolvement/the-involvement-steering-group-cb827af46401">The Involvement Steering Group</a> (ISG) set priorities on how we can drive forward involvement in Parkinson’s research and make our programme the best it can be.</p><p>Together we identified 3 priorities for 2023–2026:</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/659/0*NiT0hjK-ucwAfa5l.png" /></figure><p>So what have we done towards the priorities in 2025 and what’s coming next?</p><h3>Embedding PPI early in the research career</h3><p>We’re working to embed PPI in the work of PhD students and other early career researchers so that they have the awareness, confidence and skills to work with the Parkinson’s community throughout their research career.</p><p>Based on feedback from early career researchers we’re developing a PPI training course. We’ll be co-delivering the course, so please keep an eye out for opportunities to to be involved later on in the year!</p><p>In the meantime we’re supporting early career researchers through our PPI programme. One of which was George, a PhD student from the University of Birmingham who is investigating the role of musical groove in Parkinson’s.</p><p>George shared:</p><blockquote>“Working closely with [lived experience] co-researchers has been both rewarding and eye-opening. Their insights have shaped the project in ways I could not have achieved alone and reinforced my belief that research is stronger and more meaningful when it is co-produced with the communities it aims to benefit.”</blockquote><p>Jackie, a PPI contributor who has been working with George, said:</p><blockquote>“Working with early researchers like George is great because they are the researchers of the future, we can learn such a lot from them and also about our condition. As one explains something to an early researcher you often see clarity and thoughtfulness in what you may be discussing. Long may it continue!!!”</blockquote><h3>Improving diversity in PPI</h3><p>We need everyone with Parkinson’s to be represented in research, otherwise future treatments might not work for everyone. We’re focusing on increasing the representation of PPI contributors from Black, Asian and Mixed Heritage backgrounds, and those without a university degree.</p><p>Together with a working group we’ve updated the <a href="https://volunteer.parkinsons.org.uk/opportunities/6227-patient-and-public-involvement-ppi-research-volunteer-home-based-2019-11-13">PPI contributor role description and created a Frequently Asked Questions document</a> to address concerns.</p><p>We’ve spoken at community events to share learning and build relationships. And we’ve supported researchers to increase the diversity of those they’re working with. For example, we’ve worked in partnership to co-develop solutions to increase the diversity of those taking part in clinical trials run by a pharmaceutical company. The partnership included the Michael J Fox Foundation, Parkinson’s Foundation and people affected by Parkinson’s, and was supported by Egality Health, a community engagement agency.</p><p>Feedback from one of the members living with Parkinson’s:</p><blockquote>“It has been a privilege to participate with members from such a huge diverse community, this has enabled us all to learn so much.”</blockquote><p>Read more about the work on the Egality Health website:</p><p><a href="https://egality.health/casestudies/establishing-a-health-equity-in-rd-community-leaders-board-for-a-global-pharmaceutical-company-uk-us">Health Equity Advisory Board to Advance Fair Representation in Parkinson&#39;s Clinical Trials (US/UK) | Egality Health</a></p><h3>Evaluating the PPI programme</h3><p>Over 2025 we’ve been working with the ISG to develop a framework to evaluate how we support PPI at Parkinson’s UK. We’re piloting this in how we support PPI in grant applications.</p><p>We hope the framework will help us better understand the PPI that is taking place in our funded projects, its impact, what’s going well and where there are challenges. As well as how our PPI programme supports this and where there are gaps.</p><p>In early 2026 we’re having calls with some of our funded researchers to hear more about their experience of PPI and our support. We’d also like to hear PPI contributors’ experiences of PPI in grant applications, and will be sharing invitations later this year — we’d love to hear from you!</p><p>We’ve also been helping researchers to evaluate and capture the impact of their PPI. Kali Barawi, a researcher from the University of Cardiff shared her approach:</p><blockquote>“We developed a “You Said, We Did” document. This recorded all of the suggestions made by people affected by Parkinson’s as well as the actions we have taken in response to their feedback.”</blockquote><p>Read more about Kali’s research and how PPI contributors impacted her study in this blog:</p><p><a href="https://www.parkinsons.org.uk/research/blog/experts/learn-study-improving-access-advanced-therapies">The LEARN study: improving access to advanced therapies</a></p><p>We hope this blog has given you a flavour of some of the activities we’ve been working on and what is coming up. If you’d like to share some PPI that you’ve been involved with, or if you’d like to give feedback on any aspect of our PPI programme, please get in touch anytime!</p><p><strong>Thank you for all your time and contributions in 2025 and we look forward to working with you in 2026!</strong></p><p>Anne, Laura and Nikul</p><p><em>Parkinson’s UK Research Involvement Team</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/773/1*G1jJVWVIsK8_rTDVd7V2YA.png" /><figcaption>Anne, Nikul and Laura (Parkinson’s UK Research Involvement Team)</figcaption></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=65ff1a10c1aa" width="1" height="1" alt=""><hr><p><a href="https://medium.com/researchinvolvement/ppi-at-parkinsons-uk-reflecting-on-2025-and-looking-ahead-in-2026-65ff1a10c1aa">PPI at Parkinson’s UK: reflecting on 2025 and looking ahead in 2026</a> was originally published in <a href="https://medium.com/researchinvolvement">Patient and Public Involvement at Parkinson&#39;s UK</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[PPI at Parkinson’s UK: reflecting on 2025 and looking ahead in 2026]]></title>
            <link>https://medium.com/researchinvolvement/ppi-at-parkinsons-uk-reflecting-on-2025-and-looking-ahead-in-2026-a151473d198c?source=rss-fd0c652f8686------2</link>
            <guid isPermaLink="false">https://medium.com/p/a151473d198c</guid>
            <category><![CDATA[research]]></category>
            <category><![CDATA[patient-engagement]]></category>
            <category><![CDATA[parkinsons]]></category>
            <category><![CDATA[lived-experience]]></category>
            <dc:creator><![CDATA[Dr Laura Jacobs]]></dc:creator>
            <pubDate>Fri, 30 Jan 2026 10:53:51 GMT</pubDate>
            <atom:updated>2026-01-30T10:53:51.775Z</atom:updated>
            <content:encoded><![CDATA[<p>2025 was a busy year for the Patient and Public Involvement (PPI) programme with many activities to support and improve PPI at Parkinson’s UK. In this blog, we reflect back on our highlights and activities from the year and look to the year ahead.</p><h3>Key statistics and highlights</h3><p>In 2025 we supported researchers and people affected by Parkinson’s to work together in <strong>over 80 research projects.</strong> This is the highest number of projects in a year yet. And it doesn’t include the many long term collaborations, like advisory groups or steering committees, that many of you are involved with which started before 2025.</p><p>One exciting example is the EJSACT-PD study, the world’s largest Parkinson’s clinical trial which uses an innovative design and launched in 2025. It has been shaped throughout by people affected by Parkinson’s, including many of you. As Carroll, who is a member of the involvement group explains,</p><blockquote>‘<em>[We] share our thoughts on how the trial should be managed, what treatment to choose, what technology should be used for monitoring, where the sites should be etc.’</em></blockquote><p><a href="https://www.parkinsons.org.uk/research/blog/trials-treatments/collaborating-make-ejs-act-pd-happen">Read more about the collaboration behind the EJSACT-PD study in our blog</a>.</p><p>In 2025 we welcomed 26 new PPI contributors to the role, bringing the network up to 138 volunteers! It’s been a pleasure to meet and connect with many of you in our new ‘PPI Quarterly Connections’ online calls this year.</p><p>Whether you’re new to the role or have been a volunteer for many years, thank you for all you do to improve Parkinson’s research. Together you’re helping to make Parkinson’s research more relevant, inclusive, practical and engaging.</p><h3>Beyond the numbers</h3><p>We’re thrilled to see more and more Parkinson’s research, from lab based projects to clinical trials, being shaped by people living with Parkinson’s and those who support them. But we know there’s more to do.</p><p><a href="https://medium.com/researchinvolvement/the-involvement-steering-group-cb827af46401">The Involvement Steering Group</a> (ISG) set priorities on how we can drive forward involvement in Parkinson’s research and make our programme the best it can be.</p><p>Together we identified 3 priorities for 2023–2026:</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/659/1*NWdv5P9CHVJorlDy2GqAxQ.png" /></figure><p>So what have we done towards the priorities in 2025 and what’s coming next?</p><h3>Embedding PPI early in the research career</h3><p>We’re working to embed PPI in the work of PhD students and other early career researchers so that they have the awareness, confidence and skills to work with the Parkinson’s community throughout their research career.</p><p>Based on feedback from early career researchers we’re developing a PPI training course. We’ll be co-delivering the course, so please keep an eye out for opportunities to to be involved later on in the year!</p><p>In the meantime we’re supporting early career researchers through our PPI programme. One of which was George, a PhD student from the University of Birmingham who is investigating the role of musical groove in Parkinson’s.</p><p>George shared:</p><blockquote>“Working closely with [lived experience] co-researchers has been both rewarding and eye-opening. Their insights have shaped the project in ways I could not have achieved alone and reinforced my belief that research is stronger and more meaningful when it is co-produced with the communities it aims to benefit.”</blockquote><p>Jackie, a PPI contributor who has been working with George, said:</p><blockquote>“Working with early researchers like George is great because they are the researchers of the future, we can learn such a lot from them and also about our condition. As one explains something to an early researcher you often see clarity and thoughtfulness in what you may be discussing. Long may it continue!!!”</blockquote><h3>Improving diversity in PPI</h3><p>We need everyone with Parkinson’s to be represented in research, otherwise future treatments might not work for everyone. We’re focusing on increasing the representation of PPI contributors from Black, Asian and Mixed Heritage backgrounds, and those without a university degree.</p><p>Together with a working group we’ve updated the <a href="https://volunteer.parkinsons.org.uk/opportunities/6227-patient-and-public-involvement-ppi-research-volunteer-home-based-2019-11-13">PPI contributor role description and created a Frequently Asked Questions document</a> to address concerns.</p><p>We’ve spoken at community events to share learning and build relationships. And we’ve supported researchers to increase the diversity of those they’re working with. For example, we’ve worked in partnership to co-develop solutions to increase the diversity of those taking part in clinical trials run by a pharmaceutical company. The partnership included the Michael J Fox Foundation, Parkinson’s Foundation and people affected by Parkinson’s, and was supported by Egality Health, a community engagement agency.</p><p>Feedback from one of the members living with Parkinson’s:</p><blockquote>“It has been a privilege to participate with members from such a huge diverse community, this has enabled us all to learn so much.”</blockquote><p>Read more about the work on the Egality Health website:</p><p><a href="https://egality.health/casestudies/establishing-a-health-equity-in-rd-community-leaders-board-for-a-global-pharmaceutical-company-uk-us">Health Equity Advisory Board to Advance Fair Representation in Parkinson&#39;s Clinical Trials (US/UK) | Egality Health</a></p><h3>Evaluating the PPI programme</h3><p>Over 2025 we’ve been working with the ISG to develop a framework to evaluate how we support PPI at Parkinson’s UK. We’re piloting this in how we support PPI in grant applications.</p><p>We hope the framework will help us better understand the PPI that is taking place in our funded projects, its impact, what’s going well and where there are challenges. As well as how our PPI programme supports this and where there are gaps.</p><p>In early 2026 we’re having calls with some of our funded researchers to hear more about their experience of PPI and our support. We’d also like to hear PPI contributors’ experiences of PPI in grant applications, and will be sharing invitations later this year — we’d love to hear from you!</p><p>We’ve also been helping researchers to evaluate and capture the impact of their PPI. Kali Barawi, a researcher from the University of Cardiff shared her approach:</p><blockquote>“We developed a “You Said, We Did” document. This recorded all of the suggestions made by people affected by Parkinson’s as well as the actions we have taken in response to their feedback.”</blockquote><p>Read more about Kali’s research and how PPI contributors impacted her study in this blog:</p><p><a href="https://www.parkinsons.org.uk/research/blog/experts/learn-study-improving-access-advanced-therapies">The LEARN study: improving access to advanced therapies</a></p><p>We hope this blog has given you a flavour of some of the activities we’ve been working on and what is coming up. If you’d like to share some PPI that you’ve been involved with, or if you’d like to give feedback on any aspect of our PPI programme, please get in touch anytime!</p><p><strong>Thank you for all your time and contributions in 2025 and we look forward to working with you in 2026!</strong></p><p>Anne, Laura and Nikul</p><p><em>Parkinson’s UK Research Involvement Team</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/773/1*G1jJVWVIsK8_rTDVd7V2YA.png" /><figcaption>Anne, Nikul and Laura (The Parkinson’s UK Research Involvement Team)</figcaption></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=a151473d198c" width="1" height="1" alt=""><hr><p><a href="https://medium.com/researchinvolvement/ppi-at-parkinsons-uk-reflecting-on-2025-and-looking-ahead-in-2026-a151473d198c">PPI at Parkinson’s UK: reflecting on 2025 and looking ahead in 2026</a> was originally published in <a href="https://medium.com/researchinvolvement">Patient and Public Involvement at Parkinson&#39;s UK</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Summer 2023 — patient and public involvement (PPI) newsletter]]></title>
            <link>https://medium.com/researchinvolvement/summer-2023-patient-and-public-involvement-ppi-newsletter-b3ee2e97fb2b?source=rss-fd0c652f8686------2</link>
            <guid isPermaLink="false">https://medium.com/p/b3ee2e97fb2b</guid>
            <category><![CDATA[ppi-newsletter]]></category>
            <category><![CDATA[ppi]]></category>
            <category><![CDATA[parkinsons]]></category>
            <category><![CDATA[research]]></category>
            <dc:creator><![CDATA[Dr Laura Jacobs]]></dc:creator>
            <pubDate>Mon, 21 Aug 2023 09:52:04 GMT</pubDate>
            <atom:updated>2023-08-21T14:17:46.473Z</atom:updated>
            <content:encoded><![CDATA[<h3>Summer 2023 — patient and public involvement (PPI) newsletter</h3><p>In this edition we introduce a new member of the Research Involvement team, share updates from conferences, bring you opportunities to have your say and more!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*NihTkydiOHeBq3hb" /></figure><h3>Introducing a new member of the Research Involvement Team</h3><p>We’re really excited to have welcomed Anne Gill as Research Involvement Officer and she’s shared a message for you:</p><p><em>Hi everyone, I hope you are well and are having a lovely summer. I just wanted to introduce myself to you — my name is Anne and I joined the Research Involvement Team on the 14th August . Before joining Parkinson’s UK, I was at Alzheimer’s Research UK where I helped manage the research grant funding process.</em></p><p><em>I am really excited to be here, and I am looking forward to working with you to put your voices at the forefront of research. I am here to help you, so if there is anything I can do to make things easier for you, then please do just let me know.</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*_Hu-dHo8VlBklUpX" /></figure><h3>New results from a clinical trial for a potential dyskinesia treatment</h3><p>A clinical trial funded by the Parkinson’s UK Virtual Biotech and the Michael J Fox Foundation has recently released promising new results. The study, which is led by the company Neurolixis, aims to develop a new drug that could prevent dyskinesia (uncontrollable movements that are a side effect of current drugs).</p><p>We supported the Neurolixis team to involve people living with Parkinson’s in planning the trial, with some of you joining online discussion with the company to share your thoughts and suggestions. This led to changes in the study design, including it being shortened to reduce the burden on participants and allowing people to continue taking amantadine for their dyskinesia to avoid excluding them from taking part.</p><p>In the recent update, the company shared that, as well as showing promising results in treating dyskinesia, the trial had a positive effect on other motor symptoms of Parkinson’s, such as slowness, stiffness and tremor. Find out more about the study results and the next steps for this research in this blog by Claire Bale, our Associate Director of Research Engagement and Involvement:</p><p><a href="https://medium.com/parkinsons-uk/nlx-112-trial-results-behind-the-headlines-86e9be35a436">NLX-112 trial results — behind the headlines</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*bk5jaSHaosdwWIE5" /></figure><h3>Volunteers Week 2023</h3><p>1–7 June was National Volunteer week! Whether you’ve been a PPI contributor for many years or are new to the role, we want to say thank you for being part of research! The experience, knowledge and time you share to shape research priorities and projects is vital to improve Parkinson’s research. We believe that we will reach a cure and improve the lives of people with Parkinson’s faster, together.</p><figure><img alt="Painted blue thank you on a grey barn wall" src="https://cdn-images-1.medium.com/max/1024/0*q6vShoC5n7L1FC3G" /><figcaption>Photo by <a href="https://unsplash.com/@kevin_butz?utm_source=medium&amp;utm_medium=referral">Kevin Butz</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><p>We celebrated Volunteer’s week in a number of different ways. You may remember receiving a short video from the Research Team (if not, <a href="https://www.youtube.com/watch?v=z9N3ReN9G6U">you can find it here</a>). We also saw the return of our charity wide ‘All Volunteer Calls’ to hear about the fantastic range of activities that volunteers are doing to support the Parkinson’s community. <a href="https://volunteer.parkinsons.org.uk/portal/news/all-volunteer-calls-a-chance-to-get-involved-june-s-recording">You can access the video here</a> (you’ll need to log in to Assemble to do so. If you have any trouble logging in please let us know).</p><p>It was great to see some of you on the call! You can see Anne Ferrett sharing her ‘memorable moment’ as a PPI contributor in a research project in the call (at 00.28.46 in the recording). If you’d like to share your memorable moment as a PPI contributor, we’d love to hear it so please do get in touch at researchinvolvement@parkinsons.org.uk.</p><p>We truly appreciate all that you do and it’s a pleasure working with you. Thank you!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*B6QYZdvqxNi4te-l" /></figure><h3>Join the Involvement Steering Group</h3><p>The Involvement Steering Group (ISG) provides guidance and support to shape and develop the Parkinson’s UK patient and public involvement (PPI) programme. And we’re looking for new members to join us!</p><p>The group helps to ensure that our programme is the best it can be to support researchers and the Parkinson’s community to work in partnership to improve Parkinson’s research. This includes:</p><ul><li>Promoting and raising awareness of involvement in Parkinson’s research</li><li>Shaping resources for researchers and the Parkinson’s community</li><li>Setting and monitoring the objectives and priorities of the Parkinson’s UK PPI programme</li></ul><p>The ISG is made up of people with lived experience of Parkinson’s (including partners, family members and carers), Parkinson’s researchers, healthcare professionals and the Parkinson’s UK Research Involvement team. You don’t have to have a scientific background to be involved!</p><p>The group meets monthly by video-conference and has one to two (optional) face-to-face meetings a year.</p><p>If you’re interested in joining the ISG or would like to find out more we’d love to hear from you, please email us at <a href="http://researchinvolvement@parkinsons.org.uk/">researchinvolvement@parkinsons.org.uk</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*VYFFRWDCyfCLciZf" /></figure><h3>Co-presenting a PPI workshop at the British Neuroscience Association conference</h3><p>In April this year we presented a PPI workshop at the British Neuroscience Association conference in Brighton. Attended by people working within the British Neuroscience field, including scientists, students and representatives from companies and funding bodies, the conference is a chance for people to come together to share ideas and learn about the latest research developments.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/865/1*N_HRAmlv6vg8EjOh_3RA5A.png" /><figcaption>Brighton’s West Pier</figcaption></figure><p>The PPI workshop was co-developed and delivered by Carroll and Matthew who have Parkinson’s and are PPI contributors, Laura from the Parkinson’s UK Research Involvement team, and Parkinson’s researchers Ellen and Heather. We shared an introduction to PPI, split into small groups to discuss real examples of involvement in research and held a panel Q&amp;A.</p><p>A lot of the researchers attending were lab-based researchers. We know that this can be an area where PPI does not happen as often and researchers may feel less confident of how to involve people in their research. We believe that PPI can meaningfully be a part of lab-based research, so it was a great opportunity to share information and signpost to support and resources that are available and discuss some of the challenges and opportunities. We also really enjoyed hearing from others about projects and partnerships already underway.</p><p>Heather and Carroll shared their thoughts on how the workshop went:</p><p>Carroll:</p><blockquote>I was so pleased to see so many researchers, academics and scientists present at our workshop. They enthusiastically shared their experiences of PPI with people with Parkinson’s. The fruitful discussions between us highlighted the need for PPI towards enhancing the quality of research in neuroscience.</blockquote><p>Heather:</p><blockquote>‘The PPI workshop was a great opportunity to raise awareness and interact about including PPI in all Parkinson’s projects. It was fantastic to speak to people, from just a short workshop, people were energised to include PPI as a fundamental part of their research, new connections were made and ideas generated.’</blockquote><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*fgaPBCILEe80OTL5" /></figure><h3>Have your say: Using technology and devices for Parkinson’s</h3><p>We’ve seen many technologies that help manage our health and well-being emerge over the last decade, including some specifically designed for Parkinson’s. These developments and the potential benefits are exciting but there are also lots of questions to answer.</p><p>Parkinson’s UK is starting a new project to develop tools and resources to help people with Parkinson’s explore the range of available technologies, find the answers to their questions and access technologies that will help them.</p><p>We’d like to hear your views and experiences of using technology and devices to help us understand what information and support the community needs in this area. You can <strong>c</strong><a href="https://surveys.parkinsons.org.uk/s/ICY73G/?_ga=2.230660572.1934281628.1690879280-1186062372.1675938081"><strong>omplete the survey by</strong> <strong>clicking on this link.</strong></a></p><p>Thank you for your help! We’ll be keeping you updated on this project as it progresses.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*Snd8BYHnYMiAVSrF" /></figure><h3>Highlights from World Parkinson’s Congress 2023</h3><p>The World Parkinson’s Congress 2023 took place in Barcelona from 4 to 7 July. The congress is an opportunity for people from across the Parkinson’s community to come together to learn, share and discuss the latest scientific discoveries, care practices and more.</p><p>Nikul, Parkinson’s UK’s Research Involvement Lead, attended the conference this year, along with a number of colleagues from the Research Team and wider charity . He shared his reflections on the event:</p><p><em>The sheer volume of people who attended the congress was incredible and it was invigorating to see so many people from across the community under one roof discussing, connecting and sharing experiences and ideas. There were so many fascinating posters and talks being led by researchers and people living with Parkinson’s.</em></p><p><em>At the congress I was part of a panel sharing our experience of setting up the </em><a href="https://www.parkinsons.org.uk/news/working-together-put-patients-heart-parkinsons-research"><em>Patient Engagement Council for Parkinson’s Research</em></a><em> (PECPR) with the pharmaceutical company UCB, the Parkinson’s Foundation and people with Parkinson’s. We shared our aims of the project and our learning so far. We also presented this work in a poster, which you can r</em><a href="https://drive.google.com/file/d/11kfA0rTprSunjQpgcOB7Y1auowxcaGWm/view?usp=sharing"><em>ead by clicking on this link</em></a><em>. We hope that this will help and inspire others to embed the voice and experience of people with Parkinson’s in drug development from an early stage too.</em></p><p><em>We also presented a poster on one of the priorities identified by the PECPR, exploring how to meaningfully involve people with Parkinson’s in the development of a Target Product Profile (TPP). A TPP is a guidance tool for the development of a treatment with expected and minimally accepted characteristics. A working group was formed to develop this project. You can </em><a href="https://drive.google.com/file/d/1vH0d6IMo8UsHFpNqxneQXYlkXIJmcsZq/view?usp=sharing"><em>read more about the project and it’s outcomes in the working group’s poster, here</em></a><em>.</em></p><p><em>I spoke at an industry round table in the clinical research village and shared my experience of supporting industry to work in partnership with people with Parkinson’s and the importance of increasing the diversity of people taking part in clinical trials.</em></p><figure><img alt="Marc, Nikul and Kate standing with their conference poster, wearing their conference lanyards" src="https://cdn-images-1.medium.com/max/1024/1*WXTqWF3ArydkltwtiDzs9w.png" /><figcaption>Marc van Grieken (patient expert) , Nikul (Parkinson’s UK) and Kate Trenam (UCB) with their poster at World Parkinson’s Congress 2023.</figcaption></figure><p>We’ll be sharing a series of blogs of some of the research highlights from the conference. Dr Becky Jones, our Research Communication manager, has written the first blog on highlights from the ‘Hot Topics’ sessions, which took place first thing in the morning each day. Read the blog at the link below:</p><p><a href="https://medium.com/parkinsons-uk/highlights-from-the-world-parkinson-congress-hot-topics-710accb60476">Highlights from the World Parkinson Congress — Hot Topics</a></p><p>If you attended the Congress and presented a poster that you would like to share with the wider Parkinson’s UK PPI network, please let us know at <a href="/service/mailto:researchinvolvement@parkinsons.org.uk">researchinvolvement@parkinsons.org.uk</a>. We’d love to help to share work that you’ve been involved with!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*kxhYiWnQNURKSr3C" /></figure><h3>Online information session on different PPI roles</h3><p>The NIHR Cambridge Biomedical Research Centre (BRC) will be holding an online information session about different PPI roles in health research on Tuesday 12 September 2023, 1–2pm.</p><p>The 60 minute information session will cover different roles PPI contributors may hold in research such as attending focus groups, sitting on steering groups or being a co-applicant on a research project. As well as sharing information about the roles you’ll also hear from public contributors on their experiences in these different roles and there will be an opportunity for Q&amp;A.</p><p>The event is free and open to members of the public in the UK with an interest in PPI. Click the link below to find out more about the event and to book your space.</p><p><a href="https://www.eventbrite.co.uk/e/what-can-ppi-contributors-in-research-actually-do-for-public-tickets-669431446477?aff=ebdsoporgprofile">What can PPI contributors in research actually do? (for public)</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*kxhYiWnQNURKSr3C" /></figure><p>We really value your feedback on any aspect of our PPI programme, so please do get in touch anytime! Email us at <a href="http://researchinvolvement@parkinsons.org.uk/">researchinvolvement@parkinsons.org.uk</a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b3ee2e97fb2b" width="1" height="1" alt=""><hr><p><a href="https://medium.com/researchinvolvement/summer-2023-patient-and-public-involvement-ppi-newsletter-b3ee2e97fb2b">Summer 2023 — patient and public involvement (PPI) newsletter</a> was originally published in <a href="https://medium.com/researchinvolvement">Patient and Public Involvement at Parkinson&#39;s UK</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Spring 2023 — patient and public involvement (PPI) newsletter]]></title>
            <link>https://medium.com/researchinvolvement/spring-2023-patient-and-public-involvement-ppi-newsletter-4902f9e0e3e6?source=rss-fd0c652f8686------2</link>
            <guid isPermaLink="false">https://medium.com/p/4902f9e0e3e6</guid>
            <category><![CDATA[parkinsons]]></category>
            <category><![CDATA[research]]></category>
            <category><![CDATA[ppi-newsletter]]></category>
            <category><![CDATA[ppi]]></category>
            <dc:creator><![CDATA[Dr Laura Jacobs]]></dc:creator>
            <pubDate>Wed, 05 Apr 2023 13:57:28 GMT</pubDate>
            <atom:updated>2023-04-05T14:01:35.419Z</atom:updated>
            <content:encoded><![CDATA[<h3>Spring 2023 — patient and public involvement newsletter</h3><h4>Welcome to our <strong>first patient and public involvement (PPI) newsletter of 2023! In this edition we have some new grants, reflections on PPI partnerships, an opportunity to have your say and more.</strong></h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*8sfeeJbyXHen0cwW" /></figure><h3>Shaping research in 2022</h3><p>We’re sorry we missed our Winter newsletter last year. Hopefully you saw our message from the whole Research team highlighting some key research moments from 2022. If not, or if you’d like to recap, <a href="https://medium.com/parkinsons-uk/2022-research-moments-13d65108e1d0">you can find the blog here.</a></p><p>Last year PPI contributors shaped nearly 50 research projects! These projects have covered a huge range of Parkinson’s research, from lab-based to clinical studies and across different stages of the research cycle. From helping to identify and prioritise research questions to shaping the design of studies so they are acceptable and practical for future participants. From improving how the research is communicated to helping manage the research by being part of a steering group. You are helping to ensure Parkinson’s research is higher quality, more efficient and more meaningful to the Parkinson’s community, thank you!</p><p>Here’s some feedback from researchers that we worked with in 2022 on the impact that PPI has had on their research:</p><blockquote><em>The [advisory] group helped to shape the research questions to ensure what I was asking would lead to meaningful answers for people with Parkinson’s. They also used their lived experience to contribute to the analysis of the data and helped me to see where the literature was lacking, or to understand the nuance of certain aspects of the results.</em></blockquote><p><em>Researcher</em></p><blockquote><em>[PPI] contributors made some insightful comments re the language I used as well as how potential recruits would respond to the study design which helped shape the study in a more acceptable way.</em></blockquote><p><em>Anja Lowitt, Researcher</em></p><blockquote><em>The feedback provided on the abstract was very constructive. In particular, the feedback helped me identify parts of the abstract which required additional information and jargon to avoid or to explain.</em></blockquote><p><em>Francesco Aprile, Researcher</em></p><p>A huge thank you for all that you do to improve Parkinson’s research!</p><p>We are here to support you and answer any questions you have about being a Patient and Public Involvement volunteer. If you have any issues, feedback or positive experiences you’d like to share, please let us know. You can contact us at <a href="/service/mailto:researchinvolvement@parkinsons.org.uk">researchinvolvement@parkinsons.org.uk</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*i_PjQwK-kXxDeJPs" /></figure><h4>New Parkinson’s UK research</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*h8EkZOgghNB93z5uH68xxg.png" /></figure><p>At the start of the year we awarded three new grants to researchers who applied to our ‘<a href="https://www.parkinsons.org.uk/research/grants-non-drug-approaches">non-drug approaches’ grant round</a>:</p><ul><li>One project will build on an approved NHS exercise programme ‘Keep On Keep Up’ and find ways to adapt it for people with Parkinson’s to address balance, strength and fitness.</li><li>Another project will develop and test a programme to address key mental health needs, such as anxiety and managing memory and thinking problems in Parkinson’s.</li><li>A third project will test if an exercise game can help to change brain activity and improve balance for people with Parkinson’s.</li></ul><p>The researchers have worked with members of the Parkinson’s community (including some of you) to shape their applications. This included to ensure that the research is addressing a question that is relevant and meaningful, to shape the study design so they are feasible and practical, and ensuring the plain English summaries were clear and understandable.</p><p>We’ll be keeping you informed of any future opportunities to shape these projects, so keep an eye out for these!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*i_PjQwK-kXxDeJPs" /></figure><h3>Reflections on a long term PPI partnership published in journal</h3><p>Ellen Poliakoff, a cognitive science researcher, and Matthew Sullivan, who was a senior lecturer in Biosciences and has Parkinson’s, have been collaborating for over 10 years. Both Ellen and Matthew have been members of the Parkinson’s UK Involvement Steering Group and have been instrumental in shaping our PPI programme.</p><p>At the beginning of the year Matthew and Ellen published their reflections on their partnership in a journal. They describe how the partnership started and how it has evolved. They also share learnings they’ve gained along the way, including what they consider are key ingredients for a successful collaboration, as well as the challenges they have experienced.</p><p>Reflecting on the partnership, Matthew said:</p><blockquote><em>‘When we started this collaboration, I was relatively newly diagnosed. Ten years on, my condition has progressed, and so I now bring a new perspective. PPI collaborators have real lives too, which is exactly where the value of PPI lies.’</em></blockquote><p>Click the link below to read the full article.</p><p><a href="https://uclpress.scienceopen.com/hosted-document?doi=10.14324/RFA.07.1.01">Parkinson&#39;s from inside out: emerging and unexpected benefits of a long-term partnership</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*KC2VyOy4Ki4AQ1Vj" /></figure><h3>Developing the iFall app: progress and co-production</h3><p>Over the past 2 years, Rosie Morris, a researcher at Northumbria University, and co-investigators Elaine Webster and Gerry Standerline, who both have Parkinson’s, have been developing an app to better monitor falls in Parkinson’s.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*ASdwlSu6-AA5h5xf" /><figcaption>Photo by <a href="https://unsplash.com/ko/@jupp?utm_source=medium&amp;utm_medium=referral">Jonathan Kemper</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><p>We caught up with Rosie, Elaine and Gerry to hear how the development of the app (which is called iFall) is progressing so far and how they have been co-producing the app together.</p><p>A key aspect of the project has been bringing together different people with expertise and skills to ensure that the app is the best that it can be. Gerry shared more about the iFall team:</p><blockquote>‘<em>In our case, our team is made up of people with different skills, like different pieces of the puzzle coming together. It was essential to assemble the right people. This meant researchers like Rosie, and people with Parkinson’s like myself and Elaine, but also people with technical expertise in app development.’</em></blockquote><p>You can read more about the app, Rosie, Elaine and Gerry’s experience and their top tips for co-production in their blog, here:</p><p><a href="https://medium.com/parkinsons-uk/developing-an-app-to-record-and-help-prevent-falls-a862330bb78e">Developing an app to record and help prevent falls</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*M_jT-a4hmuVFjhvL" /></figure><h3>Parkinson’s stories</h3><p>Did you know that you can find out more about people’s personal experiences of Parkinson’s on our website?</p><p>There are over 40 different symptoms of Parkinson’s and living with the condition looks different for everyone. When designing a research study, it is important that the study is as flexible as possible for future participants to ensure that it is inclusive and accessible. PPI contributors play an important role in raising awareness of this with researchers and helping them to understand ways they might be able to do this.</p><p><a href="https://www.parkinsons.org.uk/information-and-support/your-magazine/stories">Take a look under ‘stories’ in the magazine online by clicking on this link </a>to read more about different experiences of life with Parkinson’s as told by members of the Parkinson’s community.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*JwbLbTyR21uOO6ui" /></figure><h3>Have your say: Research Support Network (RSN) survey</h3><p>Our <a href="https://www.parkinsons.org.uk/research/get-involved-research">Research Support Network (RSN)</a> brings together people driven to help find a cure and better treatments for Parkinson’s. We want to hear your thoughts on our RSN emails, taking part in research and more in our RSN survey.</p><p>Your feedback will help us shape and improve our research communications and engagement work and identify any gaps in our current Research Support Network programme.</p><p><a href="https://surveys.parkinsons.org.uk/s/RSNSurvey2023/">Complete the survey here.</a> It will be open until <strong>12 May 2023</strong>. (If you are signed up to the RSN you’ll have received this survey in the April 2023 Research Roundup email too- there’s no need to complete it twice, so please feel free to ignore this link if you’ve already done it!)</p><p>The survey will take about 20 minutes to complete and all answers are completely anonymous. If you have any questions about this survey or how the data will be used, please email Liz Nash, Research Support Network Manager, on rsn@parkinsons.org.uk.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*ZgTMwtOG7bq0XoL5" /></figure><p><em>We really value your feedback on any aspect of our PPI programme, so please do get in touch anytime! Email us at </em><a href="http://researchinvolvement@parkinsons.org.uk/"><em>researchinvolvement@parkinsons.org.uk</em></a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*cwCHDZeKXeetM2GI" /><figcaption>Photo by <a href="https://unsplash.com/fr/@daiga_ellaby?utm_source=medium&amp;utm_medium=referral">Daiga Ellaby</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=4902f9e0e3e6" width="1" height="1" alt=""><hr><p><a href="https://medium.com/researchinvolvement/spring-2023-patient-and-public-involvement-ppi-newsletter-4902f9e0e3e6">Spring 2023 — patient and public involvement (PPI) newsletter</a> was originally published in <a href="https://medium.com/researchinvolvement">Patient and Public Involvement at Parkinson&#39;s UK</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Autumn 2022- Patient and public involvement newsletter]]></title>
            <link>https://medium.com/researchinvolvement/autumn-2022-patient-and-public-involvement-newsletter-8fcfcc539c95?source=rss-fd0c652f8686------2</link>
            <guid isPermaLink="false">https://medium.com/p/8fcfcc539c95</guid>
            <category><![CDATA[research]]></category>
            <category><![CDATA[ppi]]></category>
            <category><![CDATA[parkinsons]]></category>
            <category><![CDATA[ppi-newsletter]]></category>
            <dc:creator><![CDATA[Dr Laura Jacobs]]></dc:creator>
            <pubDate>Fri, 04 Nov 2022 12:38:54 GMT</pubDate>
            <atom:updated>2022-11-04T13:57:28.000Z</atom:updated>
            <content:encoded><![CDATA[<h4>In this edition we have PPI contributors’ sharing their experience of shaping research, announcements from the Virtual Biotech, information on how to get digital support and more!</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*4O343xqxXwE3E4R6.png" /></figure><h3>Shaping research to develop biomarkers</h3><p>Tony Vernon, a researcher at King’s College London, was planning a grant application and wanted to seek the views of people with lived experience of Parkinson’s on the topic of the research.</p><p>The aim of the research proposal was to search for brain imaging biomarkers — a change in the brain that can be measured with a specific form of neuroimaging- called positron emission tomography (PET) — which may be linked to the onset and progression of Parkinson’s</p><p>Olive and Rod are two of the PPI contributors who joined two focus groups with Tony to discuss his research. They have shared their experience of the focus groups as well as their advice for researchers planning to involve people with Parkinson’s in their work. Read the blog here:</p><p><a href="https://medium.com/researchinvolvement/shaping-research-to-develop-biomarkers-our-perspective-as-ppi-contributors-8d226539aa50">Shaping research to develop biomarkers- our perspective as PPI contributors</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*4O343xqxXwE3E4R6.png" /></figure><h3>Understanding experiences of early-stage Parkinson’s</h3><p>Clinical trials require accurate tools to measure if a treatment is having an impact or not. However, current tools are limited and might not fully capture the symptoms that are most meaningful for people with early stages of the condition (for example people who have been recently diagnosed).</p><p>Parkinson’s UK has been working with pharmaceutical company UCB, the Parkinson’s Foundation in the US and 6 PPI contributors to investigate and develop more meaningful tools to assess outcomes in clinical trials for people with early-stage Parkinson’s. The PPI contributors have been involved throughout the project, including the study design and interpreting the results.</p><p>As part of the study the researchers interviewed people with early-stage Parkinson’s and their loved ones to find out about the experiences and symptoms that have the greatest impact on their everyday life. It is important that these symptoms are measured in future clinical trials testing therapies for people with early-stage Parkinson’s.</p><p>Recently the team published their findings from the interviews in the <a href="https://link.springer.com/article/10.1007/s40120-022-00375-3#Tab4">journal of Neurology and Therapy</a> (the article is freely available and has a plain language summary). You can also read more about the research on our website:</p><p><a href="https://www.parkinsons.org.uk/news/understanding-symptoms-early-after-parkinsons-diagnosis">Understanding symptoms early after Parkinson&#39;s diagnosis</a></p><p>We’ll be keeping you updated on more outcomes from this study in future newsletters.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*4O343xqxXwE3E4R6.png" /></figure><h3>Exciting updates from the Virtual Biotech</h3><p><strong>A new partnership with the Parkinson’s Foundation</strong></p><p>In August we announced that Parkinson’s UK and Parkinson’s Foundation have formed a new partnership to speed up the search for new treatments.</p><p>Over the next 3 years, the US-based Parkinson’s Foundation will invest a minimum of $3m (over £2.4m) into the Parkinson’s Virtual Biotech, our international drug discovery and development programme. Find out more <a href="https://www.parkinsons.org.uk/news/parkinsons-uk-and-parkinsons-foundation-partner-speed-search-new-treatments">here</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*HfQx-jAzTbfIpCtjFQuviA.png" /></figure><p><strong>Virtual Biotech Project announcements</strong></p><p>We’ve invested in two new Virtual Biotech projects and are making progress with the planning for a potential new GDNF trial. We are:</p><ul><li>investing £2m in Enterin’s phase 2 clinical trial of the drug ENT-01, a potential treatment for Parkinson’s Dementia. Read more<a href="https://www.parkinsons.org.uk/news/were-partnering-enterin-develop-potential-new-treatment-parkinsons-dementia"> here</a>.</li><li>investing £2.9m in a phase 2 clinical trial of PXS-4728. This drug reduces inflammation and has the potential to slow the progression of Parkinson’s. Read more <a href="https://www.parkinsons.org.uk/news/parkinsons-uk-funding-research-drug-could-slow-parkinsons-progression">here</a></li><li>moving into the next phase of planning for a potential new GDNF trial. Over the last two years we’ve been working with companies, researchers and members of the Parkinson’s community– including a number of you- to learn from the previous trial and plan a future clinical trial. In the next phase we are seeking investors to make a future trial possible. Read more <a href="https://www.parkinsons.org.uk/news/making-progress-towards-potential-new-gdnf-trial">here</a>.</li></ul><p>To learn more about the Virtual Biotech take a look at <a href="https://medium.com/parkinsons-uk/whats-the-parkinson-s-virtual-biotech-756ffdffbb44">this blog</a> written by our Research Communications Manager, Katherine Fletcher. She explains what the Virtual Biotech is, the important role it plays in Parkinson’s drug discovery and the projects being funded.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*4O343xqxXwE3E4R6.png" /></figure><h3>Increasing diversity in research: Ask the Expert</h3><p>To fully understand how Parkinson’s develops, or impacts upon people’s lives, we need to involve and include people from across the Parkinson’s community. However research often does not include the voices of people from Black, Asian and Minority Ethnic backgrounds. This means that care and new treatments may not be serving everyone in the community.</p><p>The East London Parkinson’s Disease project is working with the local Bengali community and other under-represented groups in the region to address this need to include more people in Parkinson’s research.</p><p>Becky Jones, our Research Communications Officer, spoke to Tahrina Haque and Dr Alastair Noyce to hear about the parts they play in the project. Find out more:</p><p><a href="https://medium.com/parkinsons-uk/increasing-diversity-in-research-ask-the-expert-e225da3f40be">Increasing diversity in research: Ask the Expert</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*4O343xqxXwE3E4R6.png" /></figure><h3>Free online and digital skills support</h3><p>Parkinson’s UK has partnered with AbilityNet to help people with Parkinson’s get online and boost their digital skills. This support is available across the UK.</p><p>The service is free and available to people with Parkinson’s and their carers.</p><p>The support available includes help with:</p><ul><li>setting up and using a new device, such as a tablet</li><li>assistive technology to help make using tech easier with Parkinson’s</li><li>fixing technical issues</li></ul><p>For more information, including how to get support, <a href="https://www.parkinsons.org.uk/get-involved/get-online-and-improve-your-digital-skills">visit our website</a>.</p><p>You can also call AbilityNet’s helpline on 0800 048 7642<strong> </strong>(freephone and minicom)</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*4O343xqxXwE3E4R6.png" /></figure><p><em>We really value your feedback on any aspect of our PPI programme, so please do get in touch anytime! Email us at </em><a href="http://researchinvolvement@parkinsons.org.uk/"><em>researchinvolvement@parkinsons.org.uk</em></a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*Rvq93cQbcmEdErfT" /><figcaption>Photo by <a href="https://unsplash.com/@jeremythomasphoto?utm_source=medium&amp;utm_medium=referral">Jeremy Thomas</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8fcfcc539c95" width="1" height="1" alt=""><hr><p><a href="https://medium.com/researchinvolvement/autumn-2022-patient-and-public-involvement-newsletter-8fcfcc539c95">Autumn 2022- Patient and public involvement newsletter</a> was originally published in <a href="https://medium.com/researchinvolvement">Patient and Public Involvement at Parkinson&#39;s UK</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Shaping research to develop biomarkers- our perspective as PPI contributors]]></title>
            <link>https://medium.com/researchinvolvement/shaping-research-to-develop-biomarkers-our-perspective-as-ppi-contributors-8d226539aa50?source=rss-fd0c652f8686------2</link>
            <guid isPermaLink="false">https://medium.com/p/8d226539aa50</guid>
            <category><![CDATA[parkinsons]]></category>
            <category><![CDATA[ppi]]></category>
            <category><![CDATA[case-study]]></category>
            <category><![CDATA[research]]></category>
            <dc:creator><![CDATA[Dr Laura Jacobs]]></dc:creator>
            <pubDate>Mon, 25 Jul 2022 10:01:25 GMT</pubDate>
            <atom:updated>2023-11-13T09:47:47.206Z</atom:updated>
            <content:encoded><![CDATA[<h4>People with Parkinson’s, their partners and family members play an important role in identifying and prioritising research questions and shaping research projects. Tony Vernon, a researcher at King’s College London, asked members of the Parkinson’s community to share their thoughts on his research plans. We spoke to Patient and Public Involvement (PPI) contributors Olive and Rod about their experience of being involved in this lab-based research project.</h4><p><strong>About Tony’s research</strong></p><p>Detecting Parkinson’s early and understanding how it progresses for an individual is important as it can help in planning the management and treatment of the condition.</p><p>Tony’s study aims to develop a test that can identify specific biological characteristics in the brain that are linked to Parkinson’s as early as possible. Tony’s research is focusing on detecting the loss of synapses (the connections between brain cells that allow them to communicate and regulate movement). To do this he is searching for brain imaging biomarkers — a change in the brain that can be measured with a specific form of neuroimaging- called positron emission tomography (PET) — which may be linked to the onset and progression of Parkinson’s</p><p>Tony and his colleagues are using animal models with Parkinson’s-like symptoms to better understand the potential of one possible PET biomarker ( called SV2A) to follow the onset and progression of Parkinson’s.</p><p><strong>How have people with Parkinson’s been involved?</strong></p><p>Tony was planning to submit a grant application and wanted to seek the views of people with Parkinson’s on the topic of the project. Parkinson’s UK supported Tony to connect with <a href="https://www.parkinsons.org.uk/research/patient-and-public-involvement-research">patient and public involvement</a> volunteers to discuss his research. Six people were recruited to take part in two discussion groups. The first took place online via Zoom and the second was at Tony’s lab.</p><p><em>Olive was diagnosed with Parkinson’s in 2013. She and her partner Rod became patient and public involvement volunteers because they were interested in sharing their experience of Parkinson’s to help find better treatments. Here, Olive and Rod share their reflections on being involved in Tony’s project and how people affected by Parkinson’s can make meaningful contributions to lab-based research.</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/640/1*sL7-NDqcGzsAmnlFjzoCNw.jpeg" /><figcaption>Rod and Olive</figcaption></figure><p><strong>How did you feel the discussion group went?</strong></p><p>Rod: I felt it went incredibly well. One of the key factors that contributed to this was that Tony and Frank (a member of the research team) were very down to earth, they respected the audience. After Tony and Frank presented their research plans, there was time for feedback and questions. Any depth we wanted to go to, they were happy to discuss. For me, being shown around the laboratory added to the experience. I thought it was great fun.</p><p>It was a good opportunity to learn more about Parkinson’s research. I find the research fascinating. They were quite happy to explain the real detail of what they were doing — you realise it’s really cutting edge science.</p><p>Olive: I found it extremely interesting and Tony and Frank didn’t talk down to anybody.</p><p><strong>Were there any challenges to being involved in a discussion group about lab-based research?</strong></p><p>Olive: Lab-based research projects can focus on some complex and unfamiliar topics. Because of this people might question why they should get involved with lab-based research, but we can bring different experiences. I could talk about symptoms -we can offer that different perspective of Parkinson’s.</p><p>It is important that the information is communicated clearly. If it gets too complicated it can be a waste of time.</p><p>Rod: We had a lot of questions and so it was easy to get side-tracked quite early on in answering questions that we were interested in. But having time for questions was important. We ask questions because we think about it slightly differently and it helps the researchers to understand the project from different viewpoints.</p><p><strong>Do you have any advice for researchers planning discussion groups?</strong></p><p>Rod: It’s good to meet the scientists and for me it’s more productive to meet face-to-face. But teleconferencing is also good, especially during the pandemic. Maybe a mixture of formats is a good approach.</p><p>Olive: The distance to travel or frequency of meetings might help choose the format. For me face-to-face is not a problem if it’s every few months. Another consideration is how many people to involve. I’m quite happy to sit and listen and take it all in and then make comments, whereas other people can start chatting and asking questions straight away.</p><p>Rod: Some people are quieter than others, so it’s better to have a smaller group to allow for more in depth conversations. But it’s not just about the number of people, it’s how you run the meeting. It’s important for the host to ask for people’s views and bring people into the discussion.</p><p><strong>Do you think your contribution had an impact on the research or the researchers?</strong></p><p>Rod: Whenever people get together there is always something that both sides will get from it. PPI contributors may come away with an understanding of what the researchers are trying to do and that it takes a lot of money and effort to answer these questions. You don’t have to understand the details of the science in order to benefit.</p><p>Olive was a teacher and I was a research scientist, but in a totally different area. So we can listen to people and comment, but we’re not experts in this research. But by understanding what the researchers are trying to do, because of my background and experience, I can ask why are they doing this? Or is this interesting for people with Parkinson’s?</p><p>For researchers it can be motivating to meet people living with Parkinson’s and understand more about living with the condition, what the challenges may be and how their research could help.</p><p>If you’re going to start projects, including lab based research, it’s good to have discussion up front to make sure that what you’re doing is worth doing for people with the condition.</p><p><strong><em>Read about Tony’s perspective of the discussion groups </em></strong><a href="https://sites.google.com/parkinsons.org.uk/ppi-in-lab-based-research/case-studies/tony-vernon"><strong><em>here</em></strong></a><strong><em>.</em></strong></p><p><em>With thanks to Olive and Rod and to Michelle Tong and Involvement Steering Group members Eric Deeson, Ellen Poliakoff and Gillian Granville for their guidance and input for this blog.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=8d226539aa50" width="1" height="1" alt=""><hr><p><a href="https://medium.com/researchinvolvement/shaping-research-to-develop-biomarkers-our-perspective-as-ppi-contributors-8d226539aa50">Shaping research to develop biomarkers- our perspective as PPI contributors</a> was originally published in <a href="https://medium.com/researchinvolvement">Patient and Public Involvement at Parkinson&#39;s UK</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Summer 2022- Patient and public involvement newsletter]]></title>
            <link>https://medium.com/researchinvolvement/summer-2022-patient-and-public-involvement-newsletter-c12b350c0b60?source=rss-fd0c652f8686------2</link>
            <guid isPermaLink="false">https://medium.com/p/c12b350c0b60</guid>
            <category><![CDATA[involvement]]></category>
            <category><![CDATA[research]]></category>
            <category><![CDATA[volunteer]]></category>
            <category><![CDATA[parkinsons]]></category>
            <category><![CDATA[ppi-newsletter]]></category>
            <dc:creator><![CDATA[Dr Laura Jacobs]]></dc:creator>
            <pubDate>Fri, 08 Jul 2022 13:16:55 GMT</pubDate>
            <atom:updated>2022-07-08T15:02:12.680Z</atom:updated>
            <content:encoded><![CDATA[<p>This edition includes a PPI contributor’s experience of shaping lab-based research, an opportunity to shape our research magazine and the return of Parkinson’s UK’s Volunteer Awards.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*J0RbkO52lqLH068Q" /></figure><h3>Shaping lab-based research on a new drug</h3><p>Rachel Hughes from the University of Sheffield is investigating how a novel drug is having an effect in a specific type of brain cell and if this could be a potential treatment for Parkinson’s. It is a lab-based research project (by this we mean a research study that does not have people taking part).</p><p>Rachel wanted to hear people from the Parkinson’s community’s opinions on her research idea and the use of different models (eg cells and animals) to study Parkinson’s.</p><p>PPI contributor Nicola Cooper shares her experience of joining two focus groups to help shape Rachel’s project. Nicola also shares her advice for both researchers and people affected by Parkinson’s who are thinking about planning or being involved in lab based research. Click the link below to read more:</p><p><a href="https://medium.com/researchinvolvement/shaping-lab-based-research-on-a-new-drug-my-perspective-as-a-ppi-contributor-1c4437571cf3">Shaping lab-based research on a new drug- my perspective as a PPI contributor</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*RWBNJBkOpaesZcB2" /></figure><h3>Catch up on past research events</h3><p>Did you know that you can catch up on recordings of past research events on our website? The last few months have seen a number of online events covering a range of research topics from ‘technological advances in diagnosis, treatment and symptom monitoring’ to ‘Improving mental health and well-being in Parkinson’s.</p><p>Many of the research events have been organised and hosted by <a href="https://www.parkinsons.org.uk/research/local-parkinsons-research-groups">Parkinson’s Research Interest Groups</a> from around the UK. The recordings are available and free for anyone to watch- you can find a selection of recordings as well as information about upcoming events at the link below.</p><p><a href="https://www.parkinsons.org.uk/research/research-events">Research events</a></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*RWBNJBkOpaesZcB2" /></figure><h3>Join our research magazine editorial board!</h3><p><a href="https://www.parkinsons.org.uk/research/progress-our-research-magazine">Progress is our research magazine</a>, designed to inform and engage the reader with the latest Parkinson’s research. The Progress Editorial Board helps decide the content and review the copy and design for each magazine issue. The board is made up of members of the Parkinson’s community and staff from the Research Communications Team at Parkinson’s UK- and is currently looking for 2 new members!</p><p>This is a home- based role with meetings taking place via video conference. The team are looking for volunteers who would be willing to be involved with 3 issues of the magazine over a 2 year period.</p><p>So if you have a passion for communicating about Parkinson’s research and are interested in this role, we’d love to hear from you! Find out more, including how to apply, <a href="https://volunteer.parkinsons.org.uk/opportunities/33721-editorial-board-member-home-based-2022-06-09">here</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*aKZdveiURXPJaxPO" /><figcaption>Photo by <a href="https://unsplash.com/@markfb?utm_source=medium&amp;utm_medium=referral">Mark Fletcher-Brown</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*hvQSYcNXXMxG4Yaa" /></figure><h3>Shaping research grant applications</h3><p>Since the start of the year researchers have been submitting research applications to Parkinson’s UK grant rounds, including the <a href="https://www.parkinsons.org.uk/research/project-grants">Project grant</a> and <a href="https://www.parkinsons.org.uk/research/grants-non-drug-approaches">Non-drug approaches</a> funding rounds.</p><p>Many of you have been working with researchers to help shape their applications prior to submission, including:</p><ul><li>helping to ensure that the plain English summaries are as clear as possible for the Lay Grant Reviewers- people affected by Parkinson’s who help to decide which projects should be funded.</li><li>discussing the research idea and sharing your thoughts on if it is an important topic for the Parkinson’s community.</li><li>providing feedback on the study design.</li></ul><p>We wanted to share some of the feedback that we have received from researchers on the support that they received from you and the impact it had on their applications:</p><blockquote>The feedback provided on the abstract was very constructive. In particular, they helped me identify parts of the abstract which required additional information [and] jargon to avoid or to explain. <em>Research grant applicant</em></blockquote><blockquote>I find [involving people affected by Parkinson’s] useful and essential to preparing applications. Their ideas and opinions have enriched the proposal. <em>Research grant applicant.</em></blockquote><blockquote>The PPI process has been excellent and we have all been blown away by the quality and depth of responses provided by the panel. They have been truly brilliant. <em>Research grant applicant.</em></blockquote><p>After being submitted, research applications are reviewed by scientific experts and Lay Grant Reviewers and decisions are made on which applications to fund.</p><p>We’ll update you in future newsletters about the successful applications.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*D7fUNrrzUN0rDNlU" /></figure><h3>Volunteers Week- thank you!</h3><p>1–7 of June saw us celebrate Volunteer’s week and the contribution of volunteers across the charity. If you’d like to relive some of the celebrations and hear the experiences of some fellow volunteers, the ‘Volunteers Week Volunteer Call’ is available to watch on Assemble now- log in <a href="https://volunteer.parkinsons.org.uk/portal/news/our-volunteers-week-call-relive-us-celebrating-you">here</a> to watch the call.</p><p>We would like to say a huge thank you to you all for everything that you do in your patient and public involvement volunteer roles with Parkinson’s UK. We are so grateful for the energy, time and passion that you share to shape and improve Parkinson’s research-<strong> thank you</strong>!</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*_OjgdOhXJBZHIMx1" /><figcaption>Photo by <a href="https://unsplash.com/@alexas_fotos?utm_source=medium&amp;utm_medium=referral">Alexas_Fotos</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*TqEaO8GBHiE7fTwh" /></figure><h3>Volunteer Awards 2022</h3><p>The Parkinson’s UK volunteer awards are back for 2022! Volunteers are doing amazing things and play a vital role in driving forwards Parkinson’s services, support and research. Launched 4 years ago, the awards are an opportunity to celebrate volunteers who have gone the extra mile for the Parkinson’s community and who champion our values of ‘people-first, uniting, pioneering and driven’. Hear from 4 of last year’s award winners <a href="https://www.parkinsons.org.uk/get-involved/2021-volunteer-award-winners">here</a>.</p><p>So if you know an individual or a team of volunteers who you’d like to celebrate, nominate them for an award<a href="https://www.parkinsons.org.uk/volunteer-awards"> here</a>. Nominations close at 5 pm on 27 July.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*xSl2lcNJWSxKMbZP" /></figure><h3>Working with pharma to involve the Parkinson’s community in the early stages of drug development</h3><p>In 2021 we launched a partnership with the pharmaceutical company, UCB, and a charity in the US, the Parkinson’s Foundation, to establish a ‘Patient Engagement Council for Parkinson’s Research’. The council is made up of people from each organisation and 3 people affected by Parkinson’s.</p><p>Earlier this year the Council identified a priority area to help involve the Parkinson’s community in the very early stages of drug development.</p><p>Traditionally, companies develop a “target product profile” for a new drug, outlining target characteristics such as the drug’s safety and effectiveness. There is now an increasing focus on including the value of that drug to the people who might one day take it, something known as the target patient value profile (TPVP).</p><p>The council aims to set out where and how people affected by Parkinson’s should be involved to inform and co-create the development of TPVPs in the future. Find out more about this exciting priority <a href="https://www.parkinsons.org.uk/news/progress-made-partnership-between-pharma-and-people-parkinsons">here</a>.</p><p>Recently Kate Trenam, from UCB, and Harold De Wit, one of the PPI contributors, spoke at a research lecture about their experiences and hopes for the Council. Hear what they had to say from 39.57 in<a href="https://www.youtube.com/watch?v=M72TNxavtR8&amp;t=1s"> this recording</a>.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/384/0*xSl2lcNJWSxKMbZP" /></figure><h3>National Co-production Week 2022</h3><p>And lastly, 4–9 July is National Co-production Week! The National Institute for Health and Care Research (NIHR) describes co-production in research as ‘an approach in which researchers, practitioners and the public work together, sharing power and responsibility from the start to the end of the project, including the generation of knowledge.’</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*8vhSGVDgZ70LGuky" /><figcaption>Photo by <a href="https://unsplash.com/@mocaandrew?utm_source=medium&amp;utm_medium=referral">Andrew Moca</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><p>Click <a href="https://twitter.com/NIHRinvolvement/status/1543872791740547073">here </a>to find out more about the key principles of co-production in this short animation produced and shared by the NIHR on their Twitter page.</p><p>Find out more about co-production at Parkinson’s UK <a href="https://www.parkinsons.org.uk/news/its-national-co-production-week">here</a> or <a href="https://volunteer.parkinsons.org.uk/auth/login?_ga=2.137365360.1300640278.1657122734-536632587.1622562196">log in to Assemble</a> to see some great examples that have been shared over Co-production week.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*2Ufplt6V5eanoIx-" /></figure><p><em>We really value your feedback on any aspect of our PPI programme, so please do get in touch anytime! Email us at </em><a href="http://researchinvolvement@parkinsons.org.uk/"><em>researchinvolvement@parkinsons.org.uk</em></a></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c12b350c0b60" width="1" height="1" alt=""><hr><p><a href="https://medium.com/researchinvolvement/summer-2022-patient-and-public-involvement-newsletter-c12b350c0b60">Summer 2022- Patient and public involvement newsletter</a> was originally published in <a href="https://medium.com/researchinvolvement">Patient and Public Involvement at Parkinson&#39;s UK</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[A different lunchtime for 4D pharma- sharing experience of Parkinson’s]]></title>
            <link>https://medium.com/researchinvolvement/a-different-lunchtime-for-4d-pharma-sharing-experience-of-parkinsons-ed48b8ce36c6?source=rss-fd0c652f8686------2</link>
            <guid isPermaLink="false">https://medium.com/p/ed48b8ce36c6</guid>
            <category><![CDATA[clinical-trials]]></category>
            <category><![CDATA[pharma]]></category>
            <category><![CDATA[ppi]]></category>
            <category><![CDATA[people]]></category>
            <category><![CDATA[parkinsons]]></category>
            <dc:creator><![CDATA[Dr Laura Jacobs]]></dc:creator>
            <pubDate>Fri, 20 May 2022 07:02:59 GMT</pubDate>
            <atom:updated>2022-07-12T13:27:10.773Z</atom:updated>
            <content:encoded><![CDATA[<h4>4D pharma, a UK based biotechnology company, is working with a Patient Advisory Board to shape their upcoming trial. Beverley, a member of the Patient Advisory Board, joined 4D pharma at a ‘lunch &amp; learn’ session to share her experience of living with Parkinson’s.</h4><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*DApH4uKfBqMcOAnq0MdMvA.jpeg" /><figcaption>Photo by <a href="https://unsplash.com/@nickmorrison?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Nick Morrison</a> on <a href="https://unsplash.com/s/photos/lunch-computer?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a></figcaption></figure><p><a href="https://www.4dpharmaplc.com/en">4D pharma</a> is a UK based biotechnology company focused on harnessing specific strains of bacteria as potential treatments for a range of conditions. Over the last year, with support from Parkinson’s UK, <a href="https://medium.com/parkinsons-uk/patient-board-to-shape-clinical-trials-for-pioneering-new-therapy-6f0d486151f6">4D pharma has been working with a Patient Advisory Board</a> to shape the development of their upcoming clinical trial for people with Parkinson’s.</p><p>The Patient Advisory Board is made up of six people with Parkinson’s. They are working together with 4D pharma to ensure that the study is meaningful, feasible and clearly communicated to people with the condition. This includes shaping the trial design and study documents.</p><p>In November 2021, Beverley, a member of the Patient Advisory Board, presented at a ‘lunch &amp; learn’ session for 4D pharma staff to share her experience of living with Parkinson’s.</p><h3>On the day</h3><p>Over 40 staff from 4D pharma joined an online ‘lunch and learn’ session in their lunch hour to hear Beverley talk about living with Parkinson’s. Beverley shared her journey through diagnosis, her symptoms, the day to day experience of living with Parkinson’s and how important research is to her.</p><p>Sharing why the session was important and her experience, Beverley said:</p><blockquote>“<em>Thank you to 4D pharma for this opportunity to put a human face to the staff and tell them how important their work is. The audience was attentive and asked enthusiastic and penetrating questions during and at the end</em>”</blockquote><h3>Impact of the session</h3><h4><strong>Learning about Parkinson’s</strong></h4><p>The session helped increase people’s understanding of Parkinson’s.</p><p>Most of the people who attended the session worked in the laboratory or office and may not have met someone living with Parkinson’s before. It was a valuable opportunity for 4D pharma staff to hear about Parkinson’s from the perspective of someone living with the condition.</p><p>It helped them better understand the unseen symptoms of Parkinson’s and gain insight of what it is like to live with the condition on a daily basis.</p><blockquote><em>“After the session I realised that I knew less information about Parkinson’s disease than I thought.” </em><strong>Attendee from 4D pharma</strong></blockquote><blockquote><em>“I already had a good scientific understanding of the disease, but it helped me in connecting more with the patient’s journey.”</em><strong><em> </em>Attendee from 4D pharma</strong></blockquote><p>The attendees learnt first hand about one person’s path to getting a diagnosis, her current treatment for Parkinson’s and finding ways to manage and live with Parkinson’s.</p><p>Those at the session appreciated how honestly Beverley spoke about her life with Parkinson’s — both the good days and the bad days.</p><blockquote>“<em>Having a patient open up about the honest struggles faced with Parkinson’s, rather than a completely “heroic” outlook, [was the most impactful part of the session].” </em><strong>Attendee from 4D pharma</strong></blockquote><h4><strong>The importance of involving people with Parkinson’s</strong></h4><p>In feedback gathered after the event, over 70% of respondents from 4D pharma said the session increased their feelings about the importance of working with people with the condition throughout the research process.</p><blockquote><em>“It helped make the research feel</em> <em>more like working for [the benefit of] a person rather than [just]a product.” </em><strong>Attendee from 4D pharma</strong></blockquote><p>Attendees recognised the importance of getting input from people with the condition early in the development of clinical studies, and to consider the details of the trial design from the perspective of someone living with the condition.</p><blockquote><em>“I will always consider the view of the patient in trial design. Are they able to complete the tasks required? Are we asking too much? Is what we are asking them to do really going to add the most value?” </em><strong>Attendee from 4D pharma</strong></blockquote><h4><strong>Increased motivation</strong></h4><p>When asked how they would apply learnings from the session into their day to day work, many people said that hearing from Beverley had increased their motivation and given them extra drive and focus to develop a new treatment for Parkinson’s.</p><blockquote><em>“It gives me an extra drive knowing that the work I do could have a major positive impact on someone’s life” </em><strong>Attendee from 4D pharma</strong></blockquote><p>Reflecting on the impact of the session, Louise Markinson, Programme Development Director at 4D pharma responsible for the Parkinson’s program, said:</p><blockquote>“<em>Working with the Patient Advisory Board has really made a tangible difference in my daily work and I wanted the rest of 4D pharma to feel the same</em>. <em>I was thrilled with the response from our employees to Beverley’s presentation — so often we perform our research blinkered to the human aspects of Parkinson’s. Beverley’s presentation was inspiring to a lot of our staff and we are grateful for her time and efforts along with the other Patient Board Members”.</em></blockquote><h3>What’s Next?</h3><p>The lunch and learn session demonstrated the importance of bringing researchers together with people with the condition to develop meaningful and relevant treatments.</p><p>4D pharma will continue to work with the Patient Advisory Board to inform and develop its ongoing and future Parkinson’s research.</p><p>4D pharma is currently planning a clinical trial expected to commence later in 2022. The trial will be investigating two new potential therapies harnessing the bacteria that live in the human gut (the microbiome). There is increasing evidence that there are important links between the gut and the brain, which could play a role in the onset, progression and potential treatment of Parkinson’s.</p><p>If your company is conducting Parkinson’s research, we’d love to speak to you about how we can support you to work with people affected by Parkinson’s.</p><p>And if you are someone affected by the condition, get in touch to find out how you can get more involved.</p><p>Email us at <a href="/service/mailto:researchinvolvement@parkinsons.org.uk">researchinvolvement@parkinsons.org.u<em>k</em></a><em>.</em></p><figure><a href="https://www.parkinsons.org.uk/research/volunteer-help-shape-research"><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*1pB9HQesWB0G_P5tF_JPbg.png" /></a></figure><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=ed48b8ce36c6" width="1" height="1" alt=""><hr><p><a href="https://medium.com/researchinvolvement/a-different-lunchtime-for-4d-pharma-sharing-experience-of-parkinsons-ed48b8ce36c6">A different lunchtime for 4D pharma- sharing experience of Parkinson’s</a> was originally published in <a href="https://medium.com/researchinvolvement">Patient and Public Involvement at Parkinson&#39;s UK</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Shaping research on visual training- Researchers’ experience of PPI]]></title>
            <link>https://medium.com/researchinvolvement/shaping-research-on-visual-training-researchers-experience-of-ppi-84531247705b?source=rss-fd0c652f8686------2</link>
            <guid isPermaLink="false">https://medium.com/p/84531247705b</guid>
            <category><![CDATA[parkinsons]]></category>
            <category><![CDATA[research]]></category>
            <category><![CDATA[ppi]]></category>
            <dc:creator><![CDATA[Dr Laura Jacobs]]></dc:creator>
            <pubDate>Thu, 19 May 2022 12:54:47 GMT</pubDate>
            <atom:updated>2023-11-13T09:48:49.112Z</atom:updated>
            <content:encoded><![CDATA[<h4><strong>Patient and Public Involvement (PPI) has an important role in ensuring that research studies are practical and feasible for future participants. Julia Das and Rosie Morris, researchers at Northumbria University, share their experience of holding a focus group to discuss the design of their research study with people affected by Parkinson’s.</strong></h4><p><strong>About Julia and Rosie’s research</strong></p><p>Some people with Parkinson’s experience visual disturbances that can have an impact on walking and balance.</p><p>Stroboscopic visual training (SVT) is designed to train the connections between an individual’s eyes, brain, and body. Individuals wear specialised glasses with lenses that flicker between clear and opaque. Research in athletes has shown that SVT can improve skills such as reaction times and hand-eye coordination.</p><p>Julia and Rosie are investigating if this kind of visual training might be helpful for vision and balance in Parkinson’s.</p><p><strong>About the PPI activity</strong></p><p>As part of her PhD, Julia wanted to meet with people from the Parkinson’s community to discuss the plans for the research project and make sure the study protocol was practical for future participants. She was also looking for help to ensure that the study participant information sheets were clear and understandable for people taking part.</p><p>6 people affected by Parkinson’s, including people with the condition, partners and family members, were invited to take part in an online focus group.</p><p><em>Julia is a PhD student and Rosie is her PhD supervisor. Here they share their experience including top tips for holding an online focus group with PPI contributors and the impact it has had.</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/861/1*vxGDVfdMLnS3lZH2qYfI_A.png" /><figcaption>Julia and Rosie</figcaption></figure><p><strong>How did you find the focus group- what went well and what were the challenges?</strong></p><p><strong>Julia:</strong> Although I had hosted focus groups in-person before, it was my first time holding a focus group online. I found it a really positive experience. The focus group was held in 2020 during the Covid-19 pandemic when a lot of people were focusing on their health and well-being. We were really surprised with how many people were willing to be involved.</p><p>Holding the meeting online meant that we were able to invite people from across the country, not just locally. And, as there were no travel expenses it also made it a cost-effective and efficient way to involve people. Being online also made it easy to record the meeting to refer back to.</p><p>The number of people worked well — I think any more than six people would have been too many.</p><p>There were some challenges to holding the meeting virtually. Some people with Parkinson’s find it difficult to project their voices and sometimes it was hard to hear people. Some people were also less confident using the online technology.</p><p><strong>Do you have any advice for researchers planning online focus groups?</strong></p><p><strong>Julia</strong>: I’d definitely recommend holding an online focus group, the positives of holding the meeting virtually 100 percent outweighed the negatives.</p><p>I would recommend having a step-by-step guide on how to use the online meeting platform to share before the meeting, and to offer support if people need it. It definitely helps to have at least two people to host the meeting — one person to lead the discussion and another to take notes and offer technical support to participants and respond to “chat” questions if needed.</p><p>If someone is speaking quietly or has poor internet connection and you don’t hear something, encourage participants to take their time and repeat what they said. Some of the group used a special microphone which helped them to project their voice better — that worked really well.</p><p><strong>What impact has the involvement had on your research and you?</strong></p><p><strong>Rosie: </strong>Everyone was really honest, it really helped to identify where the problems with our study were.</p><p><strong>Julia: </strong>The discussions helped us to understand if the planned study was manageable for people with Parkinson’s. For example, we changed the study design from two six week periods of SVT to two four week periods of SVT based on the group’s suggestion. We also needed to clarify some of our eligibility criteria so people were clear who could take part in the research.</p><p>The group also highlighted the importance of the language we use -for example some people prefer ‘Parkinson’s’ rather than ‘Parkinson’s disease’.</p><p>After the feedback from the focus group I felt a lot more confident when submitting the study to the ethics panel. The study was approved and we received really positive feedback about the quality of the participant information sheets and lay summary — working with PPI contributors definitely helped us produce high quality documents.</p><p>The focus group also made me feel more confident as a researcher and it added real excitement and buzz to the research we are doing. I really enjoyed talking with the group about what we do and it motivated me to want to help.</p><p><strong>Do you have any other reflections you’d like to share?</strong></p><p><strong>Julia: </strong>I understood the concept of PPI before, but the focus group really reinforced how important it is to involve people affected by the condition in our work and the impact they can have. It was a big learning experience for me.</p><p><strong>Rosie</strong>: In the future it would be better to involve people earlier in the process so they can have a bigger input into the methodology. It’s really important to be receptive to the changes that people suggest and that we can make.</p><p><strong>Julia: </strong>People in the group appreciated receiving feedback following their input and many have expressed interest in being involved again. We plan to work with the Parkinson’s community in a longer term partnership working on data analysis and, when the study is complete, communication and sharing of the results.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*xMrY8oWdLnWfksql" /><figcaption>Photo by <a href="https://unsplash.com/@lunarts?utm_source=medium&amp;utm_medium=referral">Volodymyr Hryshchenko</a> on <a href="https://unsplash.com/?utm_source=medium&amp;utm_medium=referral">Unsplash</a></figcaption></figure><p><em>With thanks to Julia and Rosie and to Michelle Tong and Involvement Steering Group members Eric Deeson, Ellen Poliakoff and Gillian Granville for their guidance and input in writing this blog.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=84531247705b" width="1" height="1" alt=""><hr><p><a href="https://medium.com/researchinvolvement/shaping-research-on-visual-training-researchers-experience-of-ppi-84531247705b">Shaping research on visual training- Researchers’ experience of PPI</a> was originally published in <a href="https://medium.com/researchinvolvement">Patient and Public Involvement at Parkinson&#39;s UK</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Shaping lab-based research on a new drug- my perspective as a PPI contributor]]></title>
            <link>https://medium.com/researchinvolvement/shaping-lab-based-research-on-a-new-drug-my-perspective-as-a-ppi-contributor-1c4437571cf3?source=rss-fd0c652f8686------2</link>
            <guid isPermaLink="false">https://medium.com/p/1c4437571cf3</guid>
            <category><![CDATA[research]]></category>
            <category><![CDATA[parkinsons]]></category>
            <category><![CDATA[case-study]]></category>
            <category><![CDATA[ppi]]></category>
            <dc:creator><![CDATA[Dr Laura Jacobs]]></dc:creator>
            <pubDate>Thu, 19 May 2022 12:46:02 GMT</pubDate>
            <atom:updated>2023-11-13T09:49:16.233Z</atom:updated>
            <content:encoded><![CDATA[<h4><strong>Nicola Cooper, a patient and public involvement (PPI) volunteer, shares her experience of joining a focus group on lab-based research being carried out by Rachel Hughes at the University of Sheffield.</strong></h4><p><strong>About the research</strong></p><p>Rachel’s PhD project is investigating how a novel drug is having an effect in a specific type of neuron generated from skin cells of people with Parkinson’s. This is a lab-based research project that also involves the use of mouse models.</p><p><strong>How have people with Parkinson’s been involved?</strong></p><p>Rachel wanted to hear people from the Parkinson’s community’s opinions on her research idea and the use of animal models. Six people from<a href="https://www.parkinsons.org.uk/research/get-involved-research"> Parkinson’s UK Research Support Network</a>, including Nicola, were invited to join two focus groups. These were held at Rachel’s lab in Sheffield. In the first meeting Rachel shared background information about the research and different types of animal models that are used. In the second meeting, there was a more in-depth look at animal models and time for people to share their opinions.</p><p><em>Nicola is a retired Biomedical Scientist. She was diagnosed with Parkinson’s and became a PPI volunteer because she believes that any research that aims to improve life for people with Parkinson’s should involve people with lived experience of the condition. Here Nicola shares her experience of being involved with Rachel’s project and advice for others who are considering planning or being involved in lab based research.</em></p><figure><img alt="" src="https://cdn-images-1.medium.com/max/332/1*9H81T2ZJb_gqNcFlPAxVAw.jpeg" /><figcaption>Nicola and her husband, Steve</figcaption></figure><p><strong><em>How did you find the focus group? What went well?</em></strong></p><p>It was really well planned and I felt prepared for the meetings. We were sent some reading material in advance, and we all did our ‘homework’. We also received some material at the end of the first workshop to look at in preparation for the following workshop.</p><p>The timing of the meetings really helped to allow for our routines or medication needs. It can take people with Parkinson’s a while to get going first thing in the morning. We didn’t start until 11 o’clock, and when we arrived there was tea and coffee provided — so there wasn’t too much getting up at the crack of dawn trying to get ready and our heads into the right space. The researchers were aware in advance that we might have medication timers going off and had built in breaks too.</p><p>The opportunity to meet other people was a positive part of the meetings. It was really nice to meet the researchers and to learn more about what they were doing in the laboratory. At the second meeting researchers from the pharmaceutical company (who are making the drugs for the research project) were also present. That was interesting for us but also for them to meet people with Parkinson’s and to meet the lab researchers that they were providing drugs for. We all got a chance to chat to the researchers during the lunch break. It meant we could actually get to know them a bit more as people.</p><p><strong>Do you have any advice for researchers planning PPI activities?</strong></p><p>I’d encourage researchers to try to involve people with a range of experiences of the condition they’re studying. Having people with different backgrounds and ages in a group is useful.</p><p>I suspect that it would be quite easy to invite the same group of people over and over again. I would love to be involved over and over again, but I think it’s important to get a variety of people involved. Especially as this provides an opportunity to communicate the research to a wider group of people- spreading the joy is a good idea!</p><p>Coordinating with charities is a good approach because they often have a group of people that they can contact.</p><p><strong>Do you have any advice for anyone planning on getting involved in research?</strong></p><p>I would encourage people to go at it with an open mind. I think especially for Parkinson’s, because it’s such a long lived condition, some people can become quite discouraged by research. It can help to approach it from an interest point of view. And to remember that I can help scientists to understand a bit more about how I live, what sort of a person I am and how this is going to affect me in general.</p><p><strong>Do you think your contribution had an impact on the research or the researchers?</strong></p><p>I think we helped the researchers to have a greater understanding of Parkinson’s and what it is like to live with the condition. Two of the researchers hadn’t had a chance to meet people with Parkinson’s before. It can be difficult for people to understand that people with Parkinson’s can be quite different — different symptoms, different experiences, different ages.</p><p>We also shared our perspective on the researchers’ ideas and the research approach. One of the questions they had was whether or not we would like them to use animal models or cell lines in the research. We all had different views about how animals are used in research. Once we’d had a discussion we could all see that sometimes using animal models is valuable, but sometimes it wouldn’t be as valuable because the systems of the animals don’t necessarily reflect the systems in humans. I think that talking about things that are quite emotive was an interesting part of the meeting.</p><p>I was a microbiologist in the NHS for most of my career. I think the fact that I can provide a bit of a scientific background but also give them an idea of what it’s like to live with Parkinson’s in the real world is really valuable.</p><p>Read about Rachel’s experience of PPI and the impact of the focus group <a href="https://sites.google.com/parkinsons.org.uk/ppi-in-lab-based-research/case-studies/rachel-hughes">here</a>.</p><p><em>With thanks to Nicola and to Michelle Tong and Involvement Steering Group members Eric Deeson, Ellen Poliakoff and Gillian Granville for their guidance and input for this blog.</em></p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=1c4437571cf3" width="1" height="1" alt=""><hr><p><a href="https://medium.com/researchinvolvement/shaping-lab-based-research-on-a-new-drug-my-perspective-as-a-ppi-contributor-1c4437571cf3">Shaping lab-based research on a new drug- my perspective as a PPI contributor</a> was originally published in <a href="https://medium.com/researchinvolvement">Patient and Public Involvement at Parkinson&#39;s UK</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>